Meta-analysis of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection  Na Huang, M.S., Bing Situ, M.S., Xiao.

Slides:



Advertisements
Similar presentations
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Advertisements

Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization  Martin D. Keltz,
A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer  William M. Buckett, M.D.  Fertility and Sterility 
Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic.
Nikolaos P. Polyzos, M. D. , Christina I. Messini, M. D. , Evangelos G
Effect of vaginal lubricants on sperm motility and chromatin integrity: a prospective comparative study  Ashok Agarwal, Ph.D., Fnu Deepinder, M.D., Marcello.
Justin J. Nork, D. O. , Jonathan H. Berger, M. D. , Donald S. Crain, M
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis  Héctor F. Escobar-Morreale, M.D., Ph.D., Manuel Luque-Ramírez,
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective,
Infertility evaluation and treatment among women in the United States
Comparison of Sperm Motility Measurement Using SQA-V Automated Sperm Analyzer and Conventional Manual Methods  R.K. Sharma, T.M. Said, A. Agarwal  Fertility.
Thyroid antibodies and gestational diabetes mellitus: a meta-analysis
Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Adherence compounds in embryo transfer media for assisted reproductive technologies: summary of a Cochrane review  Stephan Bontekoe, M.D., Neil Johnson,
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
An initial low response predicts poor outcome in in vitro fertilization/intracytoplasmic sperm injection despite improved ovarian response in consecutive.
A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women 
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial 
Changes in affect and state anxiety across an in vitro fertilization/intracytoplasmic sperm injection cycle  Neha N. Mahajan, Ph.D., Deborah A. Turnbull,
Medical treatment of ectopic pregnancy: a committee opinion
Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain  David S. Guzick, M.D.,
Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis  Juan Wen, B.S., Jie Jiang, B.S.,
Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency  Carrie.
The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility  Alexander M. Quaas, M.D.,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Prospective evaluation of luteal phase length and natural fertility
Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles  Tsung-Hsien.
Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis.
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials  Valeria M.S.
Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D
Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis  Cui Hong Zheng, M.D., Ph.D.,
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Use of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with cryptozoospermia: a meta-analysis  Nikita Abhyankar, M.B.ChB.,
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose.
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis  Dimitra Kyrou,
Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis  Reshef Tal,
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
Number of good quality embryos on day 3 is predictive for both pregnancy and implantation rates in in vitro fertilization/intracytoplasmic sperm injection.
Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.
Eva Balkenende, Taghride Dahhan, M. D. , Fulco van der Veen, M. D, Ph
Effect of treatment of a previous ectopic pregnancy on in vitro fertilization– intracytoplasmic sperm injection outcomes: a retrospective cohort study 
Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.
Metformin treatment before and during in vitro fertilization or intracytoplasmic sperm injection in women with polycystic ovary syndrome: summary of a.
Clazien A. M. Bouwmans, M. Sc. , Bea M. E. Lintsen, M. D. , Marinus J
GnRH antagonists may affect endometrial receptivity
Effectiveness of highly purified human menopausal gonadotropin vs
Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis  Byung Chul Jee, M.D., Chang Suk Suh, M.D.,
Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination  Deirdre A.
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Comparison of microdissection testicular sperm extraction, conventional testicular sperm extraction, and testicular sperm aspiration for nonobstructive.
Genetic evaluation procedures at sperm banks in the United States
A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer  William M. Buckett, M.D.  Fertility and Sterility 
Is early age at menarche a risk factor for endometriosis
The play of chance Fertility and Sterility
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Parabolic trend in endometrial thickness at embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cases with clinical pregnancy evidence 
In vitro sildenafil citrate use as a sperm motility stimulant
Prevention of menstrual migraine with perimenstrual transdermal 17-β-estradiol: a randomized, placebo-controlled, double-blind crossover study  Anna Almén-Christensson,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment  Daniel Bodri, M.D., M.Sc.,
Presentation transcript:

Meta-analysis of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection  Na Huang, M.S., Bing Situ, M.S., Xiao Chen, Ph.D., Jianqiao Liu, M.D., Pengke Yan, M.D., Ph.D., Xinhuang Kang, Ph.D., Songzhi Kong, Ph.D., Min Huang, Ph.D.  Fertility and Sterility  Volume 103, Issue 2, Pages 367-373.e5 (February 2015) DOI: 10.1016/j.fertnstert.2014.10.029 Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Forest plot comparing the effect of E2 on CPR/PA (according to the route of administration of E2). The forest plot shows no benefit of E2 supplement during the luteal phase in IVF/ICSI cycles for different routes of administration: oral (top), vaginal (middle), and transdermal (bottom) in terms of CPR/PA. A random-effects model was used because the included studies had substantial heterogeneity regarding dosage or route of medication and treatment duration. Fertility and Sterility 2015 103, 367-373.e5DOI: (10.1016/j.fertnstert.2014.10.029) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Forest plot comparing the effect of E2 on CPR/PA (according to different doses given orally). The forest plot shows that no significant effect was observed for different daily doses of oral E2 in CPR/PA: 6 mg (top), 4 mg (middle), and 2 mg (bottom). A random-effects model was used. Fertility and Sterility 2015 103, 367-373.e5DOI: (10.1016/j.fertnstert.2014.10.029) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 Funnel plot of the analysis for the effect of the different routes of administration of E2 on CPR/PA. The results of Eggers are shown to assess publication bias. Fertility and Sterility 2015 103, 367-373.e5DOI: (10.1016/j.fertnstert.2014.10.029) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 2 Funnel plot of the analysis for the effect of different does of oral E2 on CPR/PA. The results of Eggers are shown to assess publication bias. Fertility and Sterility 2015 103, 367-373.e5DOI: (10.1016/j.fertnstert.2014.10.029) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 3 Forest plot of the comparison of CPR/PA (according to GnRH agonist or GnRH antagonist cycles). The forest plot shows the results of a meta-analysis of studies comparing the effect of E2 on CPR/PA with GnRH agonist (top) and GnRH antagonist (bottom); no significant effect was observed. A random-effects model was used. Fertility and Sterility 2015 103, 367-373.e5DOI: (10.1016/j.fertnstert.2014.10.029) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions